Archive for January 2022

Selecta Biosciences Inc. has chosen Ginkgo Bioworks Holdings Inc. to develop new viral capsids for gene therapies. Read More

The majority of Optimus Ride’s engineering team is joining Magna International Inc. as part of a deal "that has Magna purchasing Optimus Ride’s assets, including the company’s underlying technology and IP," the CEO said. Read More

In the latest podcast episode of Boston Speaks Up, Raghav “Rags” Gupta shares his thoughts on entrepreneurship and ideas from his bestselling book "One to Ten: Finding Your Way from Startup to Scaleup." Read More

Good morning, Boston. My pipes didn’t freeze last night (they did last year), so I’m chalking it up to a good day so far. Here are the five things you need to know to start your busy workday, plus business confidence and a correction about bunnies. Read More

Coronavirus cases are reaching or have surpassed previous peaks for many health systems throughout the state. Massachusetts hospitals are approaching their breaking point. Read More

The Military Bowl wasn’t alone in its abrupt cancellation — college football bowl games are facing the brunt of Omicron, dealing a costly financial blow. Read More

The latest Good News Tuesday: A New England classic helps support advancements in children’s health. Read More

EQRx is planning to double its number of programs this year, file for regulatory approval for the first time both in the U.S. and abroad, and expand through partnerships. Read More

Moderna will make a $45 million upfront payment and invest another $35 million in the cell therapy developer. Read More

This season’s numbers even bested those of 2019, according to a Retailers Association of Massachusetts survey. Still, RAM President Jon Hurst is reluctant to celebrate too much. Read More